Search Results 121-130 of 13413 for Relaxin-2

  1. Bupivacaine and epinephrine (injection route) - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

  2. Neurology - Clinical trials - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  3. Neurology - Clinical trials - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  4. A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery - Mayo Clinic

    Has undergone either sleeve gastrectomy or Roux-en-Y Gastric Bypass surgery within prior 2 years ... Bariatric surgery > 2 years. Participating Mayo Clinic ...

  5. Publications - Barry A. Boilson, M.D. - Mayo Clinic

    Association of HeartMate II left ventricular assist device flow estimate with thermodilution cardiac output. ASAIO J. 2014 Sep-Oct; 60(5):513-8. View PubMed ...

  6. Neurology - Clinical trials - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  7. Neurology - Clinical trials - Mayo Clinic

    Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF. ... Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... 2 or 3 meningioma as measured by 6-month PFS rate. Minnesota Spinal Cord Injury Data Network. Rochester, Minn. This is a study to generate feasibilty data ...

  9. Neurology - Clinical trials - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  10. Neurosurgery - Clinical trials

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...